Table 2.
Prospective analysis of the association between RTL and HCC cancer risk
| RTL values | Number of total patients | Number of HCC patients (%) | Univariate | Multivariate* | Log-rank P | ||
|---|---|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | ||||
| In patients with a 1-year exclusion window (n = 323) | |||||||
| By median | |||||||
| ≤Median | 162 | 6 (3.7) | 1.00 | 1.00 | |||
| >Median | 161 | 31 (19.3) | 6.43 (2.68–15.43) | 3.1 × 10–5 | 4.93 (2.00–12.13) | 0.0005 | 1.7 × 10–6 |
| By tertile | |||||||
| 1st tertile | 108 | 3 (2.8) | 1.00 | 1.00 | |||
| 2nd tertile | 108 | 11 (10.2) | 3.31 (0.92–11.91) | 0.067 | 3.49 (0.96–12.69) | 0.058 | |
| 3rd tertile | 107 | 23 (21.5) | 10.09 (3.03–33.69) | 0.0002 | 8.30 (2.42–28.41) | 0.0008 | 2.5 × 10–6 |
| P for trend | 8.3 × 10–6 | 0.0002 | |||||
| In patients with a 2-year exclusion window (n = 258) | |||||||
| By median | |||||||
| ≤Median | 129 | 3 (2.3) | 1.00 | 1.00 | |||
| >Median | 129 | 26 (20.2) | 9.77 (2.95–32.32) | 0.0002 | 7.58 (2.24–25.72) | 0.001 | 4.4 × 10–6 |
| By tertile | |||||||
| 1st tertile | 86 | 2 (2.3) | 1.00 | 1.00 | |||
| 2nd tertile | 87 | 8 (9.2) | 3.58 (0.76–16.97) | 0.11 | 4.10 (0.86–19.69) | 0.078 | |
| 3rd tertile | 85 | 19 (22.4) | 12.23 (2.84–52.64) | 0.0008 | 10.52 (2.37–46.65) | 0.002 | 9.3 × 10–6 |
| P for trend | 3.7 × 10–5 | 0.0004 | |||||
| In patients with a 5-year exclusion window (n = 153) | |||||||
| By median | |||||||
| ≤Median | 77 | 2 (2.6) | 1.00 | 1.00 | |||
| >Median | 76 | 13 (17.1) | 7.23 (1.63–32.16) | 0.009 | 7.51 (1.56–36.18) | 0.012 | 0.002 |
| By tertile | |||||||
| 1st tertile | 51 | 2 (3.9) | 1.00 | 1.00 | |||
| 2nd tertile | 52 | 2 (3.8) | 0.84 (0.12–6.04) | 0.86 | 1.02 (0.14–7.63) | 0.98 | |
| 3rd tertile | 50 | 11 (22.0) | 6.11 (1.35–27.65) | 0.019 | 6.77 (1.37–33.38) | 0.019 | 0.0009 |
| P for trend | 0.005 | 0.008 | |||||
*Multivariate analysis adjusted for age, gender, smoking status, drinking status, family history of cancer and cirrhosis status.